MiR-224 ameliorates inflammation and symptoms in mouse model of allergic rhinitis by targeting CDK9

CONCLUSION: MiR-224 affected the pathogenesis of AR by targeting CDK9. It proves that miR-224 could be a novel potential therapeutic target for AR.PMID:34761662 | DOI:10.15586/aei.v49i6.451
Source: Allergologia et Immunopathologia - Category: Allergy & Immunology Authors: Source Type: research